Pediatric Hepatobiliary and Pancreatic Program
The Pediatric Hepatobiliary and Pancreatic Program at MassGeneral Hospital for Children diagnoses and treats infants, children and adolescents with diverse hepatic, biliary and pancreatic disorders.
Meet the Team
The Hepatobiliary & Pancreatic Program at MassGeneral Hospital for Children diagnoses and treats infants, children and adolescents with diverse hepatic, biliary and pancreatic disorders ranging from gall stones and infectious hepatitis to rare metabolic and autoimmune liver diseases.
We are a multidisciplinary program that draws on all of the specialists at MassGeneral Hospital for Children as well as Massachusetts General Hospital to provide focused, comprehensive outpatient and inpatient care. We lead in the application of current knowledge to clinical care and are at the forefront in research, finding new cures for disease.
Working closely with the Mass General Center for Transplantation, we comprise the medical component of the Pediatric Liver Transplant Program and oversee the care of pediatric patients who are waiting for a new liver as well as those who have undergone transplantation.
Reflecting the often-complex care of children with hepatobiliary disorders, our group works collaboratively with other pediatric specialists throughout MassGeneral Hospital for Children, including:
- Pediatric surgeons
- Transplant surgeons
- Interventional radiologists
- Liver and vascular radiologists
- Infectious disease specialists
- Nurse practitioners and transplant coordinators
- Social workers
- Child Life
As part of our program’s pancreatic component, we work with specialists in pulmonology, cystic fibrosis, immunology, genetics and pediatric surgery.
Hepatologists specializing in transplant medicine provide state-of-the-art care for patients before and after transplant as an integral part of the Liver Transplant Program.
All diseases involving the liver and the biliary system such as:
- Genetic/metabolic disease
- Biliary atresia
- Choledochal cysts
- Sphincter of Oddi dysfunction
- Infectious hepatitis
- Autoimmune hepatitis
- Neonatal jaundice
- Primary sclerosing cholangitis
- Hepatic masses
- Non alcoholic fatty liver disease
- Storage diseases
- Cystic fibrosis
- Mitochondrial hepatopathy
- Liver failure
- Toxin induced hepatitis/failure
- Acute and chronic pancreatitis
- Pancreatic cysts and tumors
- Cystic fibrosis
Alcohol-induced liver disease, as the name implies, is caused by excessive consumption of alcohol and is a common, but preventable, disease.
Hepatitis is the inflammation of the liver, resulting in liver cell damage and destruction. Alcoholic hepatitis is a complex problem and is a precursor to chronic liver disease and cirrhosis.
Hepatitis is the inflammation of the liver, resulting in liver cell damage and destruction. In autoimmune hepatitis, the body's own immune system destroys liver cells.
Biliary cirrhosis is a rare form of liver cirrhosis, caused by disease or defects of the bile ducts.
Cholangitis is an inflammation of the bile duct system that is usually related to a bacterial infection. The bile duct system is the drainage system that carries bile from the liver and gallbladder into the area of the small intestine called the duodenum. The infection may occur suddenly or may be chronic.
Cholecystitis is an inflammation of the gallbladder wall and nearby abdominal lining. Cholecystitis is usually caused by a gallstone in the cystic duct, the duct that connects the gallbladder to the hepatic duct.
Chronic liver disease is marked by the gradual destruction of liver tissue over time. Several liver diseases fall under this category, including cirrhosis of the liver and fibrosis of the liver.
Congenital liver defects are rare liver diseases present at birth such as biliary atresia, when the bile ducts are absent or have developed abnormally, and choledochal cyst, a malformation of the hepatic duct that can obstruct flow of bile in infants.
Cystic fibrosis (CF) is an inherited chronic disease that affects the lungs and digestive system. CF causes the body to produce thick, sticky mucus that leads to progressive lung infection and difficulty gaining weight.
Hepatitis is the inflammation of the liver, resulting in liver cell damage and destruction. Drug-induced hepatitis is rare and is caused by toxic exposure to certain medications, vitamins, herbal remedies, or food supplements.
Gallstones form when bile stored in the gallbladder hardens into stone-like material.
Hepatitis A is a highly contagious and sometimes serious liver disease caused by the hepatitis A virus.
Hepatitis B is a blood-borne microorganism transmitted by exposure to the hepatitis B virus through infectious body fluids.
Hepatitis C (once called non-A, non-B hepatitis) is a liver disease caused by a recently identified blood-borne virus.
A hiatal hernia occurs when the upper part of the stomach pushes up into the chest through a small opening in the diaphragm, the muscle that separates the stomach from the chest.
Being obese increases the risk for many diseases, especially heart disease, stroke, cancer, and diabetes.
An autoimmune disorder is any reaction or attack of a person's immune system against its own organs and tissues.
Pancreatic cancer is the fourth most common cause of cancer death in men and women in the US. Pancreatic cancer occurs when malignant cells grow out of control.
Pancreatitis is the inflammation of the pancreas. The inflammation may be sudden (acute) or ongoing (chronic).
Polycystic kidney disease (PKD) is a genetic disorder characterized by the growth of numerous cysts filled with fluid in the kidneys.
Pseudocysts of the pancreas are abnormal collections of fluid, dead tissue, pancreatic enzymes, and blood that can lead to a painful mass in the pancreas.
Hepatitis is the inflammation of the liver, resulting in liver cell damage and destruction.
The following related clinical trials and research studies are currently seeking participants at Massachusetts General Hospital. Search for clinical trials and studies in another area of interest.
Cystic Fibrosis: VX09-809-102: A Phase 2, Multicenter, Double-Blind, Placebo-Controlled, Multiple-Dose Study to Evaluate the Safety, Tolerability, Efficacy, Pharmacokinetics, and Pharmacodynamics of Lumacaftor Monotherapy, and Lumacaftor and Ivacaftor Combination Therapy in Subjects with Cystic Fibrosis, Homozygous or Heterozygous for the F508del-CFTR Mutation [Cohort 4]
This course is designed to meet one or more of the following Accreditation Council of Graduate Medical Education competencies: Patient care; Medical knowledge; Practice-based learning and improvement; Interpersonal and communication skills; Professionalism; Systems-based practice
MGHfC Pediatric Hepatobiliary and Pancreatic ProgramYawkey Center for Outpatient Care
32 Fruit Street
Boston, MA 02114
Hours: 8:30 am - 5 pm, Monday to Friday
Public Transportation Access: yes
Disabled Access: yes
Liver Transplant Clinic
165 Cambridge Street
Phone: 617-724-1218 | Fax: 617-726-2167
To schedule an appointment with a MassGeneral for Children pediatric specialist, please call 888-644-3248 or complete our online appointment form to request an appointment.
Physicians may call 888-644-3211 or use the online referral form and the Access & New Appointment Center will call your patient within 1 business day.